Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Invest ; 126(12): 4460-4468, 2016 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-27775549

RESUMO

Interactions between multiple myeloma (MM) cells and the BM microenvironment play a critical role in bortezomib (BTZ) resistance. However, the mechanisms involved in these interactions are not completely understood. We previously showed that expression of CYP26 in BM stromal cells maintains a retinoic acid-low (RA-low) microenvironment that prevents the differentiation of normal and malignant hematopoietic cells. Since a low secretory B cell phenotype is associated with BTZ resistance in MM and retinoid signaling promotes plasma cell differentiation and Ig production, we investigated whether stromal expression of the cytochrome P450 monooxygenase CYP26 modulates BTZ sensitivity in the BM niche. CYP26-mediated inactivation of RA within the BM microenvironment prevented plasma cell differentiation and promoted a B cell-like, BTZ-resistant phenotype in human MM cells that were cocultured on BM stroma. Moreover, paracrine Hedgehog secretion by MM cells upregulated stromal CYP26 and further reinforced a protective microenvironment. These results suggest that crosstalk between Hedgehog and retinoid signaling modulates BTZ sensitivity in the BM niche. Targeting these pathological interactions holds promise for eliminating minimal residual disease in MM.


Assuntos
Bortezomib/farmacologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Proteínas Hedgehog/metabolismo , Mieloma Múltiplo/tratamento farmacológico , Proteínas de Neoplasias/metabolismo , Comunicação Parácrina/efeitos dos fármacos , Tretinoína/farmacologia , Microambiente Tumoral/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Técnicas de Cocultura , Família 26 do Citocromo P450/metabolismo , Humanos , Mieloma Múltiplo/metabolismo , Mieloma Múltiplo/patologia , Plasmócitos/metabolismo , Plasmócitos/patologia , Células Estromais/metabolismo , Células Estromais/patologia
2.
Phytother Res ; 25(7): 1098-101, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22692989

RESUMO

Spilanthes spp. are used as traditional herbal medicines in Africa and India to treat malaria. Yet, to date, there are no data on the active constituents or the most effective extraction methods for this indication. The isolated alkylamides, spilanthol and undeca-2E-ene-8,10-diynoic acid isobutylamide, found in S. acmella Murr., were shown to have IC50s of 16.5 µg/mL and 41.4 µg/mL on Plasmodium falciparum strain PFB and IC50s of 5.8 µg/mL and 16.3 µg/mL for the chloroquine resistant P. falciparum K1 strain, respectively. Further investigations revealed that at relatively low concentrations, spilanthol and the water extract of S. acmella reduced the parasitemia 59% and 53% in mice infected with P. yoelii yoelii 17XNL at 5 mg/kg and 50 mg/kg, respectively. Unexpectedly, the 95% ethanol extract of S. acmella was less effective (36% reduction in parasitemia) at 50 mg/kg. These results provide the first evidence supporting S. acmella against malaria and demonstrating active constituents in S. acmella against P. falciparum.


Assuntos
Amidas/farmacologia , Antimaláricos/farmacologia , Asteraceae/química , Ácidos Graxos Insaturados/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Animais , Feminino , Concentração Inibidora 50 , Malária/tratamento farmacológico , Masculino , Camundongos , Extratos Vegetais/farmacologia , Plasmodium yoelii/efeitos dos fármacos , Alcamidas Poli-Insaturadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...